The Accelerating Cancer Cures Advisory Committee is comprised of senior oncology leaders in the collaborating companies. A valuable resource for Damon Runyon Clinical Investigators, committee members are available for discussions and advice about the process of translating discoveries into therapeutics.


Richard B. Gaynor, MD
President of Research and Development
Neon Therapeutics

Kimberly L. Blackwell, MD
Vice President of Early Phase Clinical Development and Immuno-Oncology
Eli Lilly and Co.

Jorge DiMartino, MD, PhD
Vice President of Translational Development
Celgene Corporation

Nancy Valente, MD
Vice President of Global Hematology Development
Genentech, Inc.

Eric H. Rubin, MD
Senior Vice President and Therapeutic Area Head
Oncology Early Development
Merck and Co., Inc.

Glenn Dranoff, MD
Global Head of Exploratory Immuno-Oncology
Novartis Institutes for BioMedical Research

Jeffrey A. Engelman, MD, PhD
Vice President and Global Head of Oncology
Novartis Institutes for BioMedical Research

  • You can support our innovative researchers.